Pfam Domains GO Terms
| TRF |
| Myb DNA-binding |
| regulation of shelterin complex assembly |
| negative regulation of establishment of RNA localization to telomere |
| regulation of establishment of protein-containing complex localization to telomere |
| negative regulation of establishment of protein-containing complex localization to telomere |
| regulation of establishment of RNA localization to telomere |
| negative regulation of establishment of protein localization to telomere |
| positive regulation of shelterin complex assembly |
| negative regulation of telomeric D-loop disassembly |
| negative regulation of protein localization to chromosome, telomeric region |
| negative regulation of exonuclease activity |
| regulation of telomeric D-loop disassembly |
| negative regulation of telomere maintenance via semi-conservative replication |
| negative regulation of telomeric loop disassembly |
| regulation of telomere maintenance via semi-conservative replication |
| regulation of telomeric loop disassembly |
| regulation of exonuclease activity |
| negative regulation of nuclear cell cycle DNA replication |
| ankyrin repeat binding |
| telomerase activity |
| negative regulation of nuclease activity |
| shelterin complex |
| telomeric D-loop disassembly |
| nuclear telomere cap complex |
| double-stranded telomeric DNA binding |
| G-rich strand telomeric DNA binding |
| formation of extrachromosomal circular DNA |
| t-circle formation |
| regulation of establishment of protein localization to telomere |
| telomere maintenance via telomere trimming |
| meiotic telomere clustering |
| regulation of establishment of protein localization to chromosome |
| telomeric loop disassembly |
| chromosome localization to nuclear envelope involved in homologous chromosome segregation |
| negative regulation of telomerase activity |
| telomere localization |
| regulation of protein localization to chromosome, telomeric region |
| regulation of nuclear cell cycle DNA replication |
| telomere capping |
| DNA binding, bending |
| negative regulation of telomere maintenance via telomerase |
| regulation of nuclease activity |
| telomere maintenance via telomerase |
| negative regulation of DNA-dependent DNA replication |
| negative regulation of telomere maintenance via telomere lengthening |
| telomeric DNA binding |
| telomere maintenance via telomere lengthening |
| positive regulation of microtubule polymerization |
| positive regulation of microtubule polymerization or depolymerization |
| RNA-dependent DNA biosynthetic process |
| negative regulation of telomere maintenance |
| negative regulation of DNA biosynthetic process |
| negative regulation of DNA replication |
| regulation of telomerase activity |
| regulation of microtubule polymerization |
| regulation of telomere maintenance via telomerase |
| regulation of DNA-dependent DNA replication |
| homologous chromosome segregation |
| regulation of telomere maintenance via telomere lengthening |
| chromosome organization involved in meiotic cell cycle |
| establishment of chromosome localization |
| chromosome localization |
| regulation of microtubule polymerization or depolymerization |
| regulation of telomere maintenance |
| meiotic chromosome segregation |
| telomere maintenance |
| telomere organization |
| regulation of DNA replication |
| nuclear chromosome, telomeric region |
| DNA biosynthetic process |
| meiosis I |
| regulation of DNA biosynthetic process |
| meiosis I cell cycle process |
| negative regulation of cellular protein localization |
| spindle |
| negative regulation of DNA metabolic process |
| positive regulation of protein polymerization |
| fibrillar center |
| negative regulation of chromosome organization |
| meiotic nuclear division |
| meiotic cell cycle process |
| positive regulation of chromosome organization |
| negative regulation of establishment of protein localization |
| regulation of microtubule cytoskeleton organization |
| positive regulation of supramolecular fiber organization |
| nuclear chromosome segregation |
| positive regulation of cytoskeleton organization |
| regulation of microtubule-based process |
| meiotic cell cycle |
| regulation of protein polymerization |
| microtubule binding |
| positive regulation of protein complex assembly |
| chromosome segregation |
| negative regulation of transferase activity |
| nuclear body |
| nuclear division |
| organelle fission |
| negative regulation of cell cycle process |
| protein homooligomerization |
| anatomical structure homeostasis |
| regulation of chromosome organization |
| regulation of supramolecular fiber organization |
| regulation of DNA metabolic process |
| establishment of organelle localization |
| negative regulation of organelle organization |
| regulation of protein complex assembly |
| negative regulation of hydrolase activity |
| cell division |
| protein complex oligomerization |
| positive regulation of cellular component biogenesis |
| regulation of cellular protein localization |
| regulation of cytoskeleton organization |
| negative regulation of cell cycle |
| organelle localization |
| positive regulation of organelle organization |
| positive regulation of apoptotic process |
| positive regulation of programmed cell death |
| positive regulation of cell death |
| negative regulation of cellular component organization |
| DNA metabolic process |
| regulation of establishment of protein localization |
| regulation of cell cycle process |
| negative regulation of catalytic activity |
| nucleolus |
| protein homodimerization activity |
| regulation of cellular localization |
| regulation of cellular component biogenesis |
| regulation of transferase activity |
| cell cycle process |
| response to drug |
| regulation of protein localization |
| chromosome organization |
| nucleobase-containing compound biosynthetic process |
| negative regulation of molecular function |
| heterocycle biosynthetic process |
| aromatic compound biosynthetic process |
| regulation of cell cycle |
| positive regulation of cellular component organization |
| regulation of hydrolase activity |
| regulation of organelle organization |
| organic cyclic compound biosynthetic process |
| cell cycle |
| negative regulation of cellular macromolecule biosynthetic process |
| reproductive process |
| reproduction |
| negative regulation of nucleobase-containing compound metabolic process |
| DNA binding |
| negative regulation of macromolecule biosynthetic process |
| negative regulation of cellular biosynthetic process |
| regulation of apoptotic process |
| negative regulation of biosynthetic process |
| protein-containing complex assembly |
| DNA-binding transcription factor activity, RNA polymerase II-specific |
| regulation of programmed cell death |
| cellular nitrogen compound biosynthetic process |
| homeostatic process |
| regulation of cell death |
| cellular macromolecule biosynthetic process |
| macromolecule biosynthetic process |
| establishment of localization in cell |
| protein-containing complex subunit organization |
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
| Screen | Score |
|---|---|
| Deferoxamine 11μM R07 exp350 | -1.89 |
| 5-Fluorouracil 20μM R00 exp2 | -1.74 |
| Pimelic-diphenylamide-106 0.5μM R00 exp27 | 2 |
| Gene | Correlation |
|---|---|
| TERF2 | 0.497 |
| OGFR | 0.495 |
| CHD4 | 0.49 |
| RPS12 | 0.49 |
| NOL10 | 0.488 |
| SMG7 | 0.477 |
| KCTD17 | 0.472 |
| TWISTNB | 0.472 |
| HMGCR | 0.468 |
| ORC1 | 0.464 |
| VASN | 0.459 |
| ACBD4 | 0.458 |
| SCAF1 | 0.456 |
| HTATSF1 | 0.449 |
| PAN3 | 0.448 |
| PSMA6 | 0.448 |
| DTL | 0.448 |
| DISP2 | 0.442 |
| HAP1 | 0.431 |
| PSMB4 | 0.431 |
| PSMD11 | 0.43 |
| PPM1D | 0.43 |
| XYLT2 | 0.43 |
| POLE2 | 0.429 |
| PCF11 | 0.429 |
| TCEB3CL2 | 0.429 |
| ZFAND5 | 0.428 |
| CEP192 | 0.427 |
| TSPY8 | 0.424 |
| RPL17 | 0.423 |
| BRD2 | 0.42 |
| MYH7B | 0.42 |
| CACTIN | 0.418 |
| SF3A1 | 0.418 |
| BYSL | 0.417 |
| RPS2 | 0.416 |
| EXOSC5 | 0.415 |
| PSMB1 | 0.414 |
| SF3B4 | 0.413 |
| NOP16 | 0.412 |
| MADCAM1 | 0.411 |
| RPL35 | 0.411 |
| AKIRIN2 | 0.411 |
| RRM1 | 0.41 |
| NARFL | 0.409 |
| ZNF830 | 0.408 |
| RPA2 | 0.406 |
| SMG1 | 0.405 |
| ZNF655 | 0.405 |
| HIST2H2AA4 | 0.404 |
| HIST2H2AA3 | 0.404 |
| RPL14 | 0.403 |
| IK | 0.403 |
| RIOK2 | 0.402 |
| RPL26 | 0.402 |
| TBC1D3H | 0.401 |
| TOP1MT | 0.4 |
| TCEB3C | 0.4 |
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 0/28 |
| blood | 2/28 |
| bone | 4/25 |
| breast | 2/33 |
| central nervous system | 8/56 |
| cervix | 0/4 |
| colorectal | 0/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 2/15 |
| kidney | 10/21 |
| liver | 1/20 |
| lung | 10/75 |
| lymphocyte | 0/14 |
| ovary | 5/26 |
| pancreas | 1/24 |
| peripheral nervous system | 1/16 |
| plasma cell | 2/15 |
| prostate | 0/1 |
| skin | 9/24 |
| soft tissue | 0/7 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 4/29 |
| uterus | 0/5 |
Expression Distribution